Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation

Chunyan Li,Xin Wang,Xuezhi Li,Kaixin Qiu,Fengjuan Jiao,Yidan Liu,Qingxia Kong,Yan Liu,Yili Wu

DOI: https://doi.org/10.3389/fcell.2019.00170

IF: 5.5

2019-08-22

Frontiers in Cell and Developmental Biology

Abstract:Ubiquitin-proteasome pathway (UPS) and autophagy-lysosome pathway (ALP) are the two major protein degradation pathways, which are critical for proteostasis. Growing evidence indicates that proteasome inhibition-induced ALP activation is an adaptive response. Transcription Factor EB (TFEB) is a master regulator of ALP. However, the characteristics of TFEB and its role in proteasome inhibition-induced ALP activation are not fully investigated. Here we reported that the half-life of TFEB is around 13.5 h in neuronal-like cells, and TFEB is degraded through proteasome pathway in both neuronal-like and non-neuronal cells. Moreover, proteasome impairment not only promotes TFEB accumulation but also facilitates its dephosphorylation and nuclear translocation. In addition, proteasome inhibition-induced TFEB accumulation, dephosphorylation and nuclear translocation significantly increases the expression of a number of TFEB downstream genes involved in ALP activation, including microtubule-associated protein 1B light chain-3 (LC3), particularly LC3-II, cathepsin D and lysosomal-associated membrane protein 1 (LAMP1). Furthermore, we demonstrated that proteasome inhibition increases autophagosome biogenesis but not impairs autophagic flux. Our study advances the understanding of features of TFEB and indicates that TFEB might be a key mediator of proteasome impairment-induced ALP activation.

cell biology,developmental biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how proteasome inhibition activates the autophagy - lysosome pathway (ALP), especially whether this activation is related to the dephosphorylation and nuclear translocation of transcription factor EB (TFEB). Specifically, the research focuses on the following points:

1. **Half - life of TFEB**: The research first determined the half - life of TFEB in neuron - like cells and found that it is approximately 13.5 hours, indicating that the degradation rate of TFEB in these cells is slow.

2. **Effect of proteasome inhibition on TFEB**: The research found that proteasome inhibition not only promotes the accumulation of TFEB but also promotes its dephosphorylation. Dephosphorylated TFEB is more likely to transfer from the cytoplasm to the nucleus, thereby activating the autophagy - lysosome pathway.

3. **Expression changes of TFEB downstream genes**: By detecting the expression levels of LC3, Cathepsin D and lysosome - associated membrane protein 1 (LAMP1), the research found that proteasome inhibition significantly increased the expression of these ALP - related genes.

4. **Autophagosome formation and autophagic flux**: The research further confirmed that proteasome inhibition increases autophagosome formation but does not impede autophagic flux, indicating that proteasome inhibition mainly activates ALP by increasing autophagosome formation.

In summary, this paper aims to reveal the specific mechanism by which proteasome inhibition activates the autophagy - lysosome pathway by promoting the dephosphorylation and nuclear translocation of TFEB. This finding is helpful for in - depth understanding of the interaction between the proteasome and the autophagy - lysosome pathway, as well as the key role of TFEB in this process.